(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sola City Conference Center

May 22, 2014 10:00 AM - May 23, 2014 6:10 PM

4-6 Kandasurugadai, , Chiyoda-ku,, Tokyo, 101-0062 Japan

8th DIA Annual Conference in Japan for Asian New Drug Development

Back to Agenda

SESSION3-2: Development Strategy Based on Healthcare System in Each Country

Speaker(s)

Tatsuo Watanabe, PhD

NDA Submission of Eribulin Mesilate in Asia "On the NDA Submission in Korea"

Tatsuo Watanabe, PhD

Eisai Co., Ltd., Japan

Senior Director, Medical Planning Section, Oncology hhc Unit, Eisai Japan

Shingo Shigemura

Medical Administration and Pharmaceutical Market in China - Present and Future Trend

Shingo Shigemura

CMJ Pharma, China

President

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.